We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
SPI Pharma has expanded its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Man-nogem XL Opal ...
Noramco and SPI Pharma announced they have completed work on an excipient compatibility study examining a range of options for the development of cannabidiol (CBD) solid oral dosage forms ...